Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'JENNER P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 221 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McNaught, KSP; Olanow, CW; Halliwell, B; Isacson, O; Jenner, P
      Failure of the ubiquitin-proteasome system in Parkinson's disease

      NATURE REVIEWS NEUROSCIENCE
    2. Ferger, B; Rose, S; Jenner, A; Halliwell, B; Jenner, P
      6-hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum

      NEUROREPORT
    3. Whitehead, KJ; Rose, S; Jenner, P
      Involvement of intrinsic cholinergic and GABAergic innervation in the effect of NMDA on striatal dopamine efflux and metabolism as assessed by microdialysis studies in freely moving rats

      EUROPEAN JOURNAL OF NEUROSCIENCE
    4. Iravani, MM; Costa, S; Jackson, MJ; Tel, BC; Cannizzaro, C; Pearce, RKB; Jenner, P
      GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed commonmarmosets

      EUROPEAN JOURNAL OF NEUROSCIENCE
    5. Treseder, SA; Rose, S; Jenner, P
      The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats

      EUROPEAN JOURNAL OF NEUROSCIENCE
    6. Maratos, EC; Jackson, MJ; Pearce, RKB; Jenner, P
      Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

      MOVEMENT DISORDERS
    7. Medhurst, AD; Zeng, BY; Charles, KJ; Gray, J; Reavill, C; Hunter, AJ; Shale, JA; Jenner, P
      Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-dopa treatment

      NEUROSCIENCE
    8. McNaught, KSP; Jenner, P
      Proteasomal function is impaired in substantia nigra in Parkinson's disease

      NEUROSCIENCE LETTERS
    9. Zeng, BY; Pearce, RKB; MacKenzie, GM; Jenner, P
      Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study

      JOURNAL OF NEURAL TRANSMISSION
    10. Hurley, MJ; Mash, DC; Jenner, P
      Dopamine D-1 receptor expression in human basal ganglia and changes in Parkinson's disease

      MOLECULAR BRAIN RESEARCH
    11. Jenner, P
      Parkinson's disease, pesticides and mitochondrial dysfunction

      TRENDS IN NEUROSCIENCES
    12. Ferger, B; Themann, C; Rose, S; Halliwell, B; Jenner, P
      6-Hydroxydopamine increases the hydroxylation and nitration of phenylalanine in vivo: implication of peroxynitrite formation

      JOURNAL OF NEUROCHEMISTRY
    13. Lee, M; Hyun, DH; Halliwell, B; Jenner, P
      Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation: potentiation of injury by ALS-related mutant superoxide dismutases and protection by Bcl-2

      JOURNAL OF NEUROCHEMISTRY
    14. Lee, MH; Hyun, DH; Jenner, P; Halliwell, B
      Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production

      JOURNAL OF NEUROCHEMISTRY
    15. Lee, M; Hyun, DH; Jenner, P; Halliwell, B
      Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosis

      JOURNAL OF NEUROCHEMISTRY
    16. Lee, M; Hyun, DH; Halliwell, B; Jenner, P
      Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult

      JOURNAL OF NEUROCHEMISTRY
    17. Costa, S; Iravani, MM; Pearce, RKB; Jenner, P
      Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets

      EUROPEAN JOURNAL OF PHARMACOLOGY
    18. Pearce, RKB; Heikkila, M; Linden, IB; Jenner, P
      L-dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observations

      PSYCHOPHARMACOLOGY
    19. Zeng, BY; Pearce, RKB; MacKenzie, GM; Jenner, P
      Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA

      EUROPEAN JOURNAL OF NEUROSCIENCE
    20. Riedl, AG; Watts, PM; Douek, DC; Edwards, RJ; Boobis, AR; Rose, S; Jenner, P
      Expression and distribution of CYP2C enzymes in rat basal ganglia

      SYNAPSE
    21. Treseder, SA; Smith, LA; Jenner, P
      Endogenous dopaminergic tone and dopamine agonist action

      MOVEMENT DISORDERS
    22. Olanow, CW; Obeso, J; Jenner, P
      Levodopa-induced dyskinesias - Foreword

      ANNALS OF NEUROLOGY
    23. Jenner, P
      Factors influencing the onset and persistence of dyskinesia in MPTP-treated primates

      ANNALS OF NEUROLOGY
    24. Smith, LA; Jackson, MG; Bonhomme, C; Chezaubernard, C; Pearce, RKB; Jenner, P
      Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset

      CLINICAL NEUROPHARMACOLOGY
    25. Jenner, P
      Pathophysiology and biochemistry of dyskinesia: clues for the development of non-dopaminergic treatments

      JOURNAL OF NEUROLOGY
    26. Puschban, Z; Scherfler, C; Granata, R; Laboyrie, P; Quinn, NP; Jenner, P; Poewe, W; Wenning, GK
      Autoradiographic study of striatal dopamine re-uptake sites and dopamine D-1 and D-2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts

      NEUROSCIENCE
    27. Hurley, MJ; Mash, DC; Jenner, P
      Adenosine A(2A) receptor mRNA expression in Parkinson's disease

      NEUROSCIENCE LETTERS
    28. Gallagher, IM; Jenner, P; Glover, V; Clow, A
      CuZn-superoxide dismutase transgenic mice: no effect on longevity, locomotor activity and H-3-mazindol and H-3-spiperone binding over 19 months

      NEUROSCIENCE LETTERS
    29. McNaught, KSP; Jenner, P
      Dysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor release

      NEUROSCIENCE LETTERS
    30. Perry, NSL; Houghton, PJ; Theobald, A; Jenner, P; Perry, EK
      In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    31. Alam, ZI; Halliwell, B; Jenner, P
      No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease

      JOURNAL OF NEUROCHEMISTRY
    32. Kelner, GS; Lee, MH; Clark, ME; Maciejewski, D; McGrath, D; Rabizadeh, S; Lyons, T; Bredesen, D; Jenner, P; Maki, RA
      The copper transport protein Atox1 promotes neuronal survival

      JOURNAL OF BIOLOGICAL CHEMISTRY
    33. Kanda, T; Jackson, MJ; Smith, LA; Pearce, RKB; Nakamura, J; Kase, H; Kuwana, Y; Jenner, P
      Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or withselective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys

      EXPERIMENTAL NEUROLOGY
    34. Jenner, P; Zeng, BY; Smith, LA; Pearce, RKB; Tel, B; Chancharme, L; Moachon, G
      Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset

      EXPERIMENTAL BRAIN RESEARCH
    35. Treseder, SA; Jackson, M; Jenner, P
      The effects of central aromatic amino acid DOPA decarboxylase inhibition on the motor actions of L-DOPA and dopamine agonists in MPTP-treated primates

      BRITISH JOURNAL OF PHARMACOLOGY
    36. McNaught, KSP; Jenner, P
      Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation

      BIOCHEMICAL PHARMACOLOGY
    37. Jenner, P
      Genetic susceptibility and the occurrence of Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    38. Love, S; Jenner, P
      Oxidative stress in neurological disease

      BRAIN PATHOLOGY
    39. Marshall, KA; Reist, R; Jenner, P; Halliwell, B
      The neuronal toxicity of sulfite plus peroxynitrite is enhanced by glutathione depletion: Implications for Parkinson's disease

      FREE RADICAL BIOLOGY AND MEDICINE
    40. Zeng, BY; Dass, B; Owen, A; Rose, S; Cannizzaro, C; Tel, BC; Jenner, P
      Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats

      NEUROSCIENCE LETTERS
    41. Pearce, RKB; Costa, S; Jenner, P; Marsden, CD
      Chronic supranigral infusion of BDNF in normal and MPTP-treated common marmosets

      JOURNAL OF NEURAL TRANSMISSION
    42. Rose, S; Hindmarsh, JG; Jenner, P
      Neuronal nitric oxide synthase inhibition reduces MPP+-evoked hydroxyl radical formation but not dopamine efflux in rat striatum

      JOURNAL OF NEURAL TRANSMISSION
    43. Gallagher, IM; Clow, A; Jenner, P; Glover, V
      Long-term effects of pergolide and (-)-deprenyl on H-3-mazindol and H-3-spiperone binding in rat brains

      NEUROBIOLOGY OF AGING
    44. Gallagher, IM; Clow, A; Jenner, P; Glover, V
      Effect of long-term administration of pergolide and (-)-deprenyl on age related decline in hole board activity and antioxidant enzymes in rats.

      BIOGENIC AMINES
    45. McNaught, KSP; Jenner, P
      Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures

      JOURNAL OF NEUROCHEMISTRY
    46. Riedl, AG; Watts, PM; Edwards, RJ; Schulz-Utermoehl, T; Boobis, AR; Jenner, P; Marsden, CD
      Expression and localisation of CYP2D enzymes in rat basal ganglia

      BRAIN RESEARCH
    47. Dexter, DT; Ward, RJ; Florence, A; Jenner, P; Crichton, RR
      Effects of desferrithiocin and its derivatives on peripheral iron and striatal dopamine and 5-hydroxytryptamine metabolism in the ferrocene-loaded rat

      BIOCHEMICAL PHARMACOLOGY
    48. Pearce, RKB; Jackson, M; Britton, DR; Shiosaki, K; Jenner, P; Marsden, CD
      Actions of the D-1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosets

      PSYCHOPHARMACOLOGY
    49. HOWARD MK; KERSHAW T; GIBB B; STOREY N; MACLEAN AR; ZENG BY; TEL BC; JENNER P; BROWN SM; WOOLF CJ; ANDERSON PN; COFFIN RS; LATCHMAN DS
      HIGH-EFFICIENCY GENE-TRANSFER TO THE CENTRAL-NERVOUS-SYSTEM OF RODENTS AND PRIMATES USING HERPES-VIRUS VECTORS LACKING FUNCTIONAL ICP27 ANDICP34.5

      Gene therapy
    50. KANDA T; TASHIRO T; KUWANA Y; JENNER P
      ADENOSINE A(2A) RECEPTORS MODIFY MOTOR FUNCTION IN MPTP-TREATED COMMON MARMOSETS

      NeuroReport
    51. SILVA MT; ROSE S; HINDMARSH JG; JENNER P; MARSDEN CD
      L-ARGININE PRODUCES NO-INDEPENDENT INCREASES IN DOPAMINE EFFLUX IN RAT STRIATUM

      NeuroReport
    52. SCHERFLER C; WERNING GK; GRANATA R; LABOYRIE PM; QUINN NP; JENNER P; POEWE W; MARSDEN CD
      A NEURAL TRANSPLANTATION MODEL OF STRIATONIGRAL DEGENERATION

      European journal of neuroscience
    53. RIEDL AG; WATTS PM; JENNER P; MARSDEN CD
      P450 ENZYMES AND PARKINSONS-DISEASE - THE STORY SO FAR

      Movement disorders
    54. PEARCE RKB; BANERJI T; JENNER P; MARSDEN CD
      DE-NOVO ADMINISTRATION OF ROPINIROLE AND BROMOCRIPTINE INDUCES LESS DYSKINESIA THAN L-DOPA IN THE MPTP-TREATED MARMOSET

      Movement disorders
    55. JENNER P
      OXIDATIVE MECHANISMS IN NIGRAL CELL-DEATH IN PARKINSONS-DISEASE

      Movement disorders
    56. OLANOW CW; JENNER P; BEAL MF
      CELL-DEATH AND NEUROPROTECTION IN PARKINSONS-DISEASE - PROCEEDINGS FROM THE SYMPOSIUM - NEUROPROTECTION IN PARKINSONS-DISEASE - OCTOBER 31 NOVEMBER 2, 1997 - CANNES - FOREWORD

      Annals of neurology
    57. JENNER P; OLANOW CW
      UNDERSTANDING CELL-DEATH IN PARKINSONS-DISEASE

      Annals of neurology
    58. OLANOW CW; JENNER P; BROOKS D
      DOPAMINE AGONISTS AND NEUROPROTECTION IN PARKINSONS-DISEASE

      Annals of neurology
    59. KANDA T; JACKSON MJ; SMITH LA; PEARCE RKB; NAKAMURA J; KASE H; KUWANA Y; JENNER P
      ADENOSINE A(2A) ANTAGONIST - A NOVEL ANTIPARKINSONIAN AGENT THAT DOESNOT PROVOKE DYSKINESIA IN PARKINSONIAN MONKEYS

      Annals of neurology
    60. WATTS PM; RIEDL AG; DOUEK DC; EDWARDS RJ; BOOBIS AR; JENNER P; MARSDEN CD
      COLOCALIZATION OF P450 ENZYMES IN THE RAT SUBSTANTIA-NIGRA WITH TYROSINE-HYDROXYLASE

      Neuroscience
    61. HALLIWELL B; JENNER P
      IMPAIRED CLEARANCE OF OXIDIZED PROTEINS IN NEURODEGENERATIVE DISEASES

      Lancet
    62. TEL BC; ZENG BY; PEARCE RKB; ROSE S; JENNER P; MARSDEN CD
      CHANGES IN STRIATAL PREPROENKEPHALIN A (PPE-A) AND PREPROTACHYKININ (PPT) MESSENGER-RNA EXPRESSION - THE EFFECTS OF L-DOPA, BROMOCRIPTINE, AND ROPINIROLE IN MPTP-TREATED MARMOSETS

      Neurology
    63. MARATOS E; SMITH L; JACKSON MJ; PEARCE RKB; JENNER P; MARSDEN CD
      INDUCING DYSKINESIA IN MPTP-TREATED COMMON MARMOSETS - THE EFFECTS OFREPEATED TREATMENT WITH COMBINATIONS OF L-DOPA AND ROPINIROLE

      Neurology
    64. GU M; OWEN AD; TOFFA SEK; COOPER JM; DEXTER DT; JENNER P; MARSDEN CD; SCHAPIRA AHV
      MITOCHONDRIAL-FUNCTION, GSH AND IRON IN NEURODEGENERATION AND LEWY BODY DISEASES

      Journal of the neurological sciences
    65. REIST M; MARSHALL KA; JENNER P; HALLIWELL B
      TOXIC EFFECTS OF SULFITE IN COMBINATION WITH PEROXYNITRITE ON NEURONAL CELLS

      Journal of neurochemistry
    66. SPENCER JPE; JENNER P; DANIEL SE; LEES AJ; MARSDEN DC; HALLIWELL B
      CONJUGATES OF CATECHOLAMINES WITH CYSTEINE AND GSH IN PARKINSONS-DISEASE - POSSIBLE MECHANISMS OF FORMATION INVOLVING REACTIVE OXYGEN SPECIES

      Journal of neurochemistry
    67. LYRAS L; PERRY RH; PERRY EK; INCE PG; JENNER A; JENNER P; HALLIWELL B
      OXIDATIVE DAMAGE TO PROTEINS, LIPIDS, AND DNA IN CORTICAL BRAIN-REGIONS FROM PATIENTS WITH DEMENTIA WITH LEWY BODIES

      Journal of neurochemistry
    68. KAUR H; LYRAS L; JENNER P; HALLIWELL B
      ARTIFACTS IN HPLC DETECTION OF 3-NITROTYROSINE IN HUMAN BRAIN-TISSUE

      Journal of neurochemistry
    69. SENARATNE RH; MOBASHERI H; PAPAVINASASUNDARAM KG; JENNER P; LEA EA; DRAPER P
      EXPRESSION OF A GENE FOR A PORIN-LIKE PROTEIN OF THE OMPA FAMILY FROMMYCOBACTERIUM-TUBERCULOSIS H37RV

      Journal of bacteriology
    70. REIST M; JENNER P; HALLIWELL B
      SULFITE ENHANCES PEROXYNITRITE-DEPENDENT ALPHA(1)-ANTIPROTEINASE INACTIVATION - A MECHANISM OF LUNG INJURY BY SULFUR-DIOXIDE

      FEBS letters
    71. ROSE S; HINDMARSH JG; JENNER P
      MPP-EVOKED HYDROXYL RADICAL FORMATION IN THE RAT STRIATUM IN-VIVO IS ALTERED BY THE MONOAMINE-OXIDASE INHIBITORS SELEGILINE AND CLORGYLINE,BUT NOT PARGYLINE()

      British Journal of Pharmacology
    72. GILBERT E; EDWARDS R; SCHULZUTERMOEHL T; BOOBIS A; ROSE S; JENNER P
      EXPRESSION OF P450 ENZYMES IN PRIMARY RAT VENTRAL MESENCEPHALIC CULTURE

      British Journal of Pharmacology
    73. IRAVANI MM; BABWAH R; ROSE S; JENNER P
      TRANSIENT INDUCTION OF INDUCIBLE NITRIC-OXIDE SYNTHASE IMMUNOREACTIVITY IN NMDA RECEPTOR-MEDIATED NEUROTOXICITY IN THE RAT CAUDATE-PUTAMEN

      British Journal of Pharmacology
    74. RIEDL AG; BROWN CT; ROSE S; SCHULZUTERMOEHL T; EDWARDS RJ; BOOBIS AR; JENNER P
      LOCALIZATION OF CYP2D ENZYMES IN NAIVE RAT BASAL GANGLIA

      British Journal of Pharmacology
    75. TRESEDER SA; SMITH L; JACKSON M; JENNER P; MARSDEN CD
      THE FICTIONS OF L-DOPA AND DOPAMINE AGONISTS FOLLOWING DOPAMINE DEPLETION IN MPTP-TREATED COMMON MARMOSETS

      British Journal of Pharmacology
    76. MARATOS E; SMITH L; JACKSON MJ; PEARCE RKB; JENNER P; MARSDEN CD
      EFFECTS OF REPEATED TREATMENT WITH COMBINATIONS OF L-DOPA AND ROPINIROLE ON DYSKINESIA INDUCTION IN MPTP-TREATED COMMON MARMOSETS

      British Journal of Pharmacology
    77. SMITH LA; CHEETHAM S; MARATOS E; HEAL DJ; JENNER P; MARSDEN CD
      BTS-74398 REVERSES MOTOR DEFICITS IN MPTP-TREATED COMMON MARMOSETS WITHOUT INDUCING DYSKINESIAS

      British Journal of Pharmacology
    78. MCNAUGHT KS; CARRUPT PA; ALTOMARE C; CELLAMARE S; CAROTTI A; TESTA B; JENNER P; MARSDEN CD
      ISOQUINOLINE DERIVATIVES AS ENDOGENOUS NEUROTOXINS IN THE ETIOLOGY OFPARKINSONS-DISEASE

      Biochemical pharmacology
    79. SILVA MT; SCHAPIRA AHV; JENNER P
      UNEXPECTED FINDINGS OF STUDY OF SELEGILINE HAVE NOT BEEN TREATED WITHCAUTION ITS AUTHORS ADVISED

      BMJ. British medical journal
    80. MACKENZIE GM; JACKSON MJ; JENNER P; MARSDEN CD
      NITRIC-OXIDE SYNTHASE INHIBITION AND MPTP-INDUCED TOXICITY IN THE COMMON MARMOSET

      Synapse
    81. SMITH LA; GORDIN A; JENNER P; MARSDEN CD
      ENTACAPONE ENHANCES LEVODOPA-INDUCED REVERSAL OF MOTOR DISABILITY IN MPTP-TREATED COMMON MARMOSETS

      Movement disorders
    82. GERLACH M; DOUBLE K; RIEDERER P; HIRSCH E; JELLINGER K; JENNER P; TRAUTWEIN A; YOUDIM MBH
      IRON IN THE PARKINSONIAN SUBSTANTIA-NIGRA

      Movement disorders
    83. ARUOMA OI; SPENCER JPE; WARREN D; JENNER P; BUTLER J; HALLIWELL B
      CHARACTERIZATION OF FOOD ANTIOXIDANTS, ILLUSTRATED USING COMMERCIAL GARLIC AND GINGER PREPARATIONS

      Food chemistry
    84. OWEN AD; SCHAPIRA AHV; JENNER P; MARSDEN CD
      INDEXES OF OXIDATIVE STRESS IN PARKINSONS-DISEASE, ALZHEIMERS-DISEASEAND DEMENTIA WITH LEWY BODIES

      Journal of neural transmission. Supplementum
    85. PEARCE RKB; OWEN A; DANIEL S; JENNER P; MARSDEN CD
      ALTERATIONS IN THE DISTRIBUTION OF GLUTATHIONE IN THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE

      Journal of neural transmission
    86. ROSE S; HINDMARSH JG; COLLINS P; JENNER P
      THE EFFECT OF FENFLURAMINE DOSAGE REGIMEN AND REDUCED FOOD-INTAKE ON LEVELS OF 5-HT IN RAT-BRAIN

      Journal of neural transmission
    87. TOFFA S; KUNIKOWSKA GM; ZENG BY; JENNER P; MARSDEN CD
      GLUTATHIONE DEPLETION IN RAT-BRAIN DOES NOT CAUSE NIGROSTRIATAL PATHWAY DEGENERATION

      Journal of neural transmission
    88. JENNER P; PEARCE RKB; BANERJI T; DESAI NB; JACKSON MJ; MARSDEN CD
      A COMPARISON OF ROPINIROLE, L-DOPA, AND BROMOCRIPTINE TREATMENT ON THE DEVELOPMENT OF DYSKINESIA IN MPTP-TREATED COMMON MARMOSETS

      Neurology
    89. ALAM ZI; JENNER A; DANIEL SE; LEES AJ; CAIRNS N; MARSDEN CD; JENNER P; HALLIWELL B
      OXIDATIVE DNA-DAMAGE IN THE PARKINSONIAN BRAIN - AN APPARENT SELECTIVE INCREASE IN 8-HYDROXYGUANINE LEVELS IN SUBSTANTIA-NIGRA

      Journal of neurochemistry
    90. ALAM ZI; DANIEL SE; LEES AJ; MARSDEN DC; JENNER P; HALLIWELL B
      A GENERALIZED INCREASE IN PROTEIN CARBONYLS IN THE BRAIN IN PARKINSONS BUT NOT INCIDENTAL LEWY-BODY-DISEASE

      Journal of neurochemistry
    91. LYRAS L; CAIRNS NJ; JENNER A; JENNER P; HALLIWELL B
      AN ASSESSMENT OF OXIDATIVE DAMAGE TO PROTEINS, LIPIDS, AND DNA IN BRAIN FROM PATIENTS WITH ALZHEIMERS-DISEASE

      Journal of neurochemistry
    92. ZENG BY; TEL BC; PEARCE RKB; SMITH LA; CHANCHARME L; MOACHON G; ROSE S; JENNER P; MARSDEN CD
      NEUROPROTECTIVE EFFECT OF MODAFINIL AGAINST MPTP TOXICITY IN MPTP-TREATED COMMON MARMOSETS

      British Journal of Pharmacology
    93. TEL BC; ZENG BY; PEARCE RKB; ROSE S; JENNER P; MARSDEN CD
      DIFFERENTIAL-EFFECTS OF ROPINIROLE, BROMOCRIPTINE AND L-DOPA ON STRIATAL PREPROENKEPHALIN AND PREPROTACHYKININ MESSENGER-RNA EXPRESSION IN MPTP-TREATED COMMON MARMOSETS

      British Journal of Pharmacology
    94. COSTA S; PEARCE RKB; JENNER P; MARSDEN CD
      INTRAVENTRICULAR ADMINISTRATION OF GLIAL-CELL-LINE-DERIVED NEUROTROPHIC FACTOR IN THE MPTP-TREATED COMMON MARMOSET

      British Journal of Pharmacology
    95. BROWN CT; RIEDL AG; WATTS P; ROSE S; JENNER P
      HEME OXYGENASE EXPRESSION IN THE SUBSTANTIA-NIGRA OF RAT AND MARMOSET

      British Journal of Pharmacology
    96. OWEN AD; KUNIKOWSKA GM; ROSE S; JENNER P; MARSDEN CD
      CHRONIC GLUTATHIONE DEPLETION DOES NOT INDUCE MPTP TOXICITY IN THE RAT

      British Journal of Pharmacology
    97. ROSE S; WARREN D; WALGAMA O; JENNER P
      ROPINIROLE AND BROMOCRIPTINE PREVENT MPP-EVOKED HYDROXYL RADICAL FORMATION IN THE RAT STRIATUM IN-VIVO()

      British Journal of Pharmacology
    98. TEL BC; ZENG BY; PEARCE RKB; ROSE S; JENNER P; MARSDEN CD
      DIFFERENTIAL-EFFECTS OF ROPINIROLE, BROMOCRIPTINE AND L-DOPA ON STRIATAL DOPAMINE D-2 RECEPTOR-BINDING IN MPTP-TREATED COMMON MARMOSETS

      British Journal of Pharmacology
    99. WATTS PM; RIEDL AG; DOUEK DC; EDWARDS RJ; BOOBIS AR; JENNER P
      CYP2C13 AND TYROSINE-HYDROXYLASE EXPRESSION IN THE 6-HYDROXYDOPAMINE LESIONED (6-OHDA) RAT

      British Journal of Pharmacology
    100. ZENG BY; HEALES SJR; BRAND MP; LAND JM; CLARK JB; JENNER P; MARSDEN CD
      ALTERATIONS IN STRIATAL PREPROTACHYKININ AND NIGRAL TYROSINE-HYDROXYLASE MESSENGER-RNA IN TETRAHYDROBIOPTERIN-DEFICIENT MICE

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/05/20 alle ore 11:22:29